FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20530711000001100: Candesartan 32mg tablets (Krka UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2573691000001118 Candesartan 32mg tablets (Krka UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2573701000001118 Candesartan 32mg tablets (Krka UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Candesartan 32mg tablets (Krka UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Is a Product containing precisely candesartan cilexetil 32 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Has active ingredient Candesartan cilexetil false Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Has specific active ingredient Candesartan cilexetil true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Krka UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Candesartan 32mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Candesartan 32mg tablets (Krka UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start